Coronavirus Vaccine Problems News StoriesExcerpts of Key Coronavirus Vaccine Problems News Stories in Major Media
This comprehensive list of coronavirus vaccine problems news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
One hundred and six people who had been fully vaccinated against the coronavirus died from the disease in Massachusetts by the end of July, according to the state Department of Public Health. Six new deaths among breakthrough cases were reported Tuesday, along with more than 2,000 new cases. The department also reported 445 breakthrough hospitalizations in the state.
Note: Much of the full article at the link above greatly downplays this information. Yet Massachusetts has 7 million people or about 1/50th of the population of the US. So it is likely that somewhere around 5,000 fully vaccinated people in the US have died. Are these shots as effective as they are touted to be? And why is this getting virtually no attention in the media? For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Moderna's vaccine may be best against Delta. The mRNA vaccine from Pfizer and BioNTech may be less effective than Moderna's against the Delta variant of the coronavirus, according to two reports posted on medRxiv on Sunday ahead of peer review. In a study of more than 50,000 patients in the Mayo Clinic Health System, researchers found the effectiveness of Moderna's vaccine against infection had dropped to 76% in July - when the Delta variant was predominant - from 86% in early 2021. Over the same period, the effectiveness of the Pfizer/BioNTech vaccine had fallen to 42% from 76%. While both vaccines remain effective at preventing COVID hospitalization, a Moderna booster shot may be necessary soon for anyone who got the Pfizer or Moderna vaccines earlier this year, said Dr. Venky Soundararajan ... who led the Mayo study. In a separate study, elderly nursing home residents in Ontario produced stronger immune responses - especially to worrisome variants - after the Moderna vaccine than after the Pfizer/BioNTech vaccine. The elderly may need higher vaccine doses, boosters, and other preventative measures, said Anne-Claude Gingras ... who led the Canadian study. When asked to comment on both research reports, a Pfizer spokesperson said, "We continue to believe... a third dose booster may be needed within 6 to 12 months after full vaccination to maintain the highest levels of protection."
Note: The Pfizer injection effectiveness has dropped to 42%, yet virtually no media are reporting on this. Is it surprising that those who got the jab will likely need another dose to protect them against the Delta variant? And of course there will be other variants. Big Pharma is jumping with joy at the prospect of all of these extra profits. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Scientists who studied a big COVID-19 outbreak in Massachusetts concluded that vaccinated people who got so-called breakthrough infections carried about the same amount of the coronavirus as those who did not get the shots. Health officials on Friday released details of that research, which was key in this week's decision by the Centers for Disease Control and Prevention to recommend that vaccinated people return to wearing masks indoors. The authors said the findings suggest the CDC's mask guidance should be expanded to include the entire country, even outside of hot spots. The findings have the potential to upend past thinking about how the disease is spread. Previously, vaccinated people who got infected were thought to have low levels of virus and to be unlikely to pass it to others. But the new data shows that is not the case with the delta variant. The outbreak in Provincetown – a seaside tourist spot on Cape Cod in the county with Massachusetts' highest vaccination rate – has so far included more than 900 cases. About three-quarters of them were people who were fully vaccinated. Leaked internal documents ... suggest the CDC may be considering other changes in advice on how the nation fights the coronavirus, such as recommending masks for everyone and requiring vaccines for doctors and other health workers. People with breakthrough infections make up an increasing portion of hospitalizations and in-hospital deaths among COVID-19 patients.
Note: Read also about a surge in reports of serious injuries after receiving COVID injections. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
About three-fourths of people infected in a Massachusetts Covid-19 outbreak were fully vaccinated against the coronavirus with four of them ending up in the hospital, according to new data published Friday by the Centers for Disease Control and Prevention. The new data, published in the U.S. agency’s Morbidity and Mortality Weekly Report, also found that fully vaccinated people who get infected carry as much of the virus in their nose as unvaccinated people, and could spread it to other individuals. “This finding is concerning and was a pivotal discovery leading to CDC’s updated mask recommendation,” CDC Director Dr. Rochelle Walensky said. “The masking recommendation was updated to ensure the vaccinated public would not unknowingly transmit virus to others, including their unvaccinated or immunocompromised loved ones.” On Tuesday, the CDC reversed course on its prior guidance and recommended fully vaccinated Americans who live in areas with high Covid infection rates resume wearing face masks indoors. The guidelines cover about two-thirds of the U.S. population. While the delta variant continues to hit unvaccinated people the hardest, some vaccinated people could be carrying higher levels of the virus than previously understood and are potentially transmitting it to others, Walensky told reporters. The data published Friday was based on 469 cases of Covid associated with multiple summer events. Approximately three-quarters, or 74%, of the cases occurred in fully vaccinated people.
Note: Will we now need a new vaccine for any new variant? That would certainly be most profitable for big Pharma. The CDC now says those vaccinated are as likely to spread COVID as those who are not vaccinated. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
The cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies weren’t profiteering from their monopolies on COVID-19 vaccines, campaigners from The People’s Vaccine Alliance said today. New analysis by the Alliance shows that the firms Pfizer/BioNTech and Moderna are charging governments as much as $41 billion above the estimated cost of production. Colombia, for example, has potentially overpaid by as much as $375 million for its doses of the Pfizer/BioNTech and Moderna vaccines, in comparison to the estimated cost price. Despite a rapid rise in COVID cases and deaths across the developing world, Pfizer/BioNTech and Moderna have sold over 90 percent of their vaccines so far to rich countries, charging up to 24 times the potential cost of production. Neither company have agreed to fully transfer vaccine technology and know-how with any capable producers in developing countries, a move that could increase global supply, drive down prices and save millions of lives. Analysis of production techniques for the leading mRNA type vaccines produced by Pfizer/BioNTech and Moderna which were only developed thanks to public funding to the tune of $8.3 billion suggest these vaccines could be made for as little as $1.20 a dose. Yet COVAX, the scheme set up to help countries get access to COVID vaccines, has been paying, on average, nearly five times more.
Strong sales of its COVID-19 vaccine and other medicines helped Pfizer nearly double its second-quarter revenue and boost its profit an impressive 59%, beating Wall Street expectations and leading the drug giant to sharply hike its 2021 sales and profit forecasts. Amid the surging coronavirus pandemic, the COVID-19 vaccine became Pfizer’s top seller, bringing in nearly half its revenue — $7.84 billion from direct sales and revenue split with its partner, Germany's BioNTech. Pfizer now anticipates revenue from the two-dose vaccine this year to reach $33.5 billion for the 2.1 billion doses it's contracted to provide by year end. That doesn't include a contract struck last week to provide an additional 200 million doses to the U.S. The New York company on Wednesday disclosed that ongoing testing of a booster shot, given six months after the second vaccine dose, showed it raised antibody levels against the more-transmissible Delta variant to 11 times higher in older people and five times higher in younger people, compared to levels after two doses. Pfizer has delivered more than 1 billion doses of the vaccine globally and expects to make 3 billion doses this year, with many more going to low- and middle-income countries from now through year's end. Most doses of all the COVID-19 vaccines produced in Europe and the U.S. so far have gone to wealthy countries.
Note: When public health is at stake, should private companies be making huge profits like this? Read more in this information article. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering and coronavirus vaccines from reliable major media sources.
The new coronavirus variants have raised concerns about whether vaccines will remain effective against this disease. But the vaccines themselves could drive the evolution of more mutants. The virus is always mutating. And if one happens to produce a mutation that makes it less vulnerable to the vaccine, that virus could simply multiply in a vaccinated individual. But even if that happens, that's only one step in the process. If the vaccine keeps virus levels low, even mutated viruses, the infected person won't produce enough to spread to other people. Unfortunately, at the moment, scientists can't answer the most basic questions about this process. How much does the virus actually replicate inside a person who has been vaccinated with either one dose or two? And how effective is that vaccine at limiting infection enough so that the virus levels stay low and prevent the spread to other people? Andrew Read at Penn State University says, whatever the answers may be, vaccine resistance or escape, as it's called, isn't nearly as scary as bacteria becoming resistant to antibiotics. And this evolutionary pressure is present for any vaccine that doesn't completely block infection. Many vaccines, apparently, including the COVID vaccines, do not completely prevent a virus from multiplying inside someone even though these vaccines do prevent serious illness.
Note: This informative article presents further data that vaccines lead to increased mutation in viruses. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
At least 10 out of 26 Indonesian doctors who have died from Covid-19 this month had been fully vaccinated with Sinovac, prompting health experts to consider whether medics should receive alternative doses to boost immunity. Indonesia, which has relied on the Chinese-made vaccine for its health workers, is struggling with a new surge in coronavirus cases. On Monday the country announced 20,694 new infections. In Kudus, a town in central Java, more than 500 medical workers have tested positive for Covid-19 over the last two weeks, including one doctor who died. All were fully vaccinated. The data, released by the risk mitigation team of the Indonesian Medical Association (IMA), adds to questions about the level of protection that Sinovac provides against new, more infectious variants. The vaccine was approved for emergency use this month by the World Health Organization, which said efficacy results showed it prevented symptomatic disease in 51% of those vaccinated, and prevented severe Covid-19 and hospitalisation in 100% of the studied population. However, several countries that have vaccinated a large proportion of their population and used the Chinese-made Sinovac or Sinopharm vaccines as part of their inoculation campaigns have reported recent outbreaks. These include Mongolia, Seychelles, Bahrain and Chile.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
One remarkable aspect of the Covid-19 pandemic has been how often unpopular scientific ideas, from the lab-leak theory to the efficacy of masks, were initially dismissed, even ridiculed, only to resurface later. Another reversal in thinking may be imminent. Some scientists have raised concerns that the safety risks of Covid-19 vaccines have been underestimated. But the politics of vaccination has relegated their concerns to the outskirts of scientific thinking. The Vaccine Adverse Event Reporting System, or Vaers ... is a database that allows Americans to document adverse events that occur after receiving a vaccine. Vaers data for Covid-19 vaccines shows an interesting pattern. Among the 310 million Covid-19 vaccines administered, several adverse events are reported at high rates in the days immediately following vaccination, then drop sharply thereafter. The silence around these potential signals of harm reflects the policy surrounding Covid-19 vaccines. The stigma of such concerns is bad for scientific integrity and could harm patients. Four serious adverse events follow this arc, according to data directly from Vaers: low platelet count (thrombocytopenia); non-infectious myocarditis or inflammation of the heart, especially in those under 30; deep vein thrombosis. The implication is that the risks of a Covid-19 vaccine may outweigh the benefits for some low-risk populations, such as children, young adults, and people who have recovered from Covid-19.
Note: This article is also available here. Read a revealing article on how the WHO is flip flopping on the safety of vaccines for children. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
A CDC safety group said there’s a “likely association” between a rare heart inflammatory condition in adolescents and young adults mostly after they’ve received their second Covid-19 vaccine shot, citing the most recent data available. There have been more than 1,200 cases of a myocarditis or pericarditis mostly in people 30 and under who received Pfizer’s or Moderna’s Covid vaccine, according to a series of slide presentations published Wednesday for a meeting of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices. Myocarditis is the inflammation of the heart muscle, while pericarditis is the inflammation of the membrane surrounding the heart. The agency said there have been 267 cases of myocarditis or pericarditis reported after receiving one dose of the mRNA vaccines and 827 reported cases after two doses through June 11. Roughly 300 million of the shots had been administered as of June 11. Men under 30 make up the bulk of the cases, the CDC said. Of the 295 people who have developed the condition and have been discharged, 79% of them have fully recovered. Nine people were hospitalized, with two in intensive care as of June 11. The CDC is coordinating its investigation with the Food and Drug Administration, which last month authorized the Pfizer-BioNTech vaccine for adolescents ages 12 to 15. Symptoms, which include chest pain and shortness of breath, typically develop within a week of receiving the shot with most developing within four days, the agency said.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
The COVID-19 vaccines’ second dose can pack a heavy punch. But while most people experience flu-like symptoms and complain of a sore arm, musician and anti-lockdown activist Eric Clapton says his side effects included frozen limbs. Clapton wrote a note recently to Italian architect Robin Monotti Graziadei, who has shared numerous anti-lockdown posts on social media, where he called his experience receiving the AstraZeneca vaccine “disastrous.” The former Cream guitarist said he got the vaccine in February. “I took the first jab of AZ and straight away had severe reactions which lasted ten days, I recovered eventually and was told it would be twelve weeks before the second one,” Clapton wrote. “About six weeks later I was offered and took the second AZ shot,” he continued. “Needless to say the reactions were disastrous, my hands and feet were either frozen, numb or burning, and pretty much useless for two weeks, I feared I would never play again, (I suffer with peripheral neuropathy and should never have gone near the needle.) But the propaganda said the vaccine was safe for everyone.” The side effects of the AstraZeneca vaccine — which has not been approved yet for use in the U.S. — are described by the U.K. government as “mild to moderate in nature” and are expected to go away after a few days.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
The CDC announced Thursday that it will convene a meeting of its advisers on June 18th to discuss rare but higher-than-expected reports of heart inflammation following doses of the mRNA-based Pfizer and Moderna COVID-19 vaccines. So far, the CDC has identified 226 reports that might meet the agency's "working case definition" of myocarditis and pericarditis following the shots, the agency disclosed Thursday. The CDC first described the panel's session as an "emergency meeting," but later changed it to merely a "COVID-19 meeting." Previous times the advisors convened to discuss the pandemic — like their May 12th gathering to mull recommendations for Pfizer's COVID-19 vaccine in adolescents — were also described as "emergency meetings." The new details about myocarditis and pericarditis emerged first in presentations to a panel of independent advisers for the Food and Drug Administration, who are meeting Thursday to discuss how the regulator should approach emergency use authorization for using COVID-19 vaccines in younger children. The CDC previously disclosed that reports of heart inflammation were detected mostly in younger men and teenage boys following their second dose, and that there was a "higher number of observed than expected" cases in 16- to 24-year-olds. "Risk-benefit considerations … will need to account for this information,” [said] Dr. Marion Gruber, director of the FDA's vaccine office.”
Note: What this article fails to mention is that for every case reported there are very likely many that go unreported. Explore a much more in-depth article on this. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
All covid-19 vaccines currently in use in the US are available under emergency access only. None of the covid-19 vaccines in use are actually “approved.” Through an emergency access mechanism known as Emergency Use Authorisation (EUA), the products being rolled out still technically remain “investigational.” Factsheets distributed to vaccinees are clear: “There is no FDA approved vaccine to prevent covid-19.” One key difference between EUA and approval (also called “licensure,” and which for vaccines is known as a BLA (Biologics License Application)) was the expected length of follow-up of trial participants. Unlike its clear articulation of two months for an EUA, the FDA has not committed to a clear minimum for approval. Among the six “first in disease” vaccines approved by the FDA since 2006, pre-licensure pivotal trials were a median of 23 months in duration. Duration of protection is not the only question that longer, placebo controlled trials can address. They also address vaccine safety. The BMJ asked Moderna, Pfizer, and Janssen (Johnson and Johnson) what proportion of trial participants were now formally unblinded, and how many originally allocated to placebo have now received a vaccine. Pfizer declined to say, but Moderna announced that “as of April 13, all placebo participants have been offered the Moderna covid-19 vaccine and 98% of those have received the vaccine.” In other words, the trial is unblinded, and the placebo group no longer exists.
Over the past two weeks, Seychelles — which has been dubbed “the most vaccinated country in the world” — has seen a spike in coronavirus cases, causing alarm. The archipelago in the Indian Ocean, with a population of about 98,000, has fully vaccinated more than 60% of its population, but it’s also seen its number of active COVID-19 cases nearly double over the past month. The country has closed schools and canceled activities to attempt to curb the spread. Though Seychelles has been called the world’s “most vaccinated country,” not all vaccines are created equal. The country used two vaccines to inoculate its population — Sinopharm, a Chinese state-owned vaccine, and Covishield, a version of the AstraZeneca vaccine, both of which have not been proven to be as effective as the Pfizer-BioNTec and Moderna vaccines. Just last week, the WHO expressed “very low confidence” in data provided by Sinopharm around its risk of severe side effects. Recent clinical trial data found the vaccine was about 78.1% effective after two doses, but the Seychelles outbreak could suggest that the efficacy is less than that. Places like Seychelles also didn’t see huge COVID surges earlier in the pandemic, and have lower levels of natural immunity in their communities. Chile is another example of a country with a high vaccination rate that now is seeing a spike in COVID-19 cases. Its number of new daily cases nearly doubled in April from the prior month, even though the country has vaccinated more than 45% of its population.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus vaccine from reliable major media sources.
No vaccine provides perfect protection, and so-called breakthrough infections after coronavirus vaccination are rare. Federal health officials have told fully vaccinated people they no longer need to wear masks or maintain social distance because they are protected, nor do they need to be tested or quarantine after an exposure, unless they develop symptoms. Now, the Centers for Disease Control and Prevention has stopped investigating breakthrough infections among fully vaccinated people unless they become so sick that they are hospitalized or die. Earlier this year, the agency was monitoring all cases. Through the end of April, when some 101 million Americans had been vaccinated, the C.D.C. had received 10,262 reports of breakthrough infections from 46 states and territories, a number that was very likely “a substantial undercount,” according to a C.D.C. report. On May 1, the agency decided to investigate only the most severe breakthrough infection cases, while still collecting voluntary reports on breakthrough cases from state and local health departments. The agency will carry out vaccine effectiveness studies that include data on breakthrough cases, but only in limited populations, such as health care workers and essential workers, older adults, and residents at long-term care facilities. But even relatively mild cases of Covid-19 can lead to persistent long-term health problems, and it will be difficult to know the full scope without tracking mild infections as well.
Note: This is a convenient way to make it look like case numbers are dropping more than they actually are, which makes the vaccines look more effective than they really are. Learn more on how the CDC is manipulating case figures in this article. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus vaccine from reliable major media sources.
Covid-19 vaccines have created at least nine new billionaires after shares in companies producing the shots soared. Topping the list of new billionaires are Moderna CEO St©phane Bancel and Ugur Sahin, the CEO of BioNTech, which has produced a vaccine with Pfizer. Both CEOs are now worth around $4 billion, according to an analysis by the People's Vaccine Alliance, a campaign group that includes Oxfam, UNAIDS, Global Justice Now and Amnesty International. Senior executives from China's CanSino Biologics and early investors in Moderna have also become billionaires on paper as shares skyrocketed. Moderna's share price has gained more than 700% since February 2020, while BioNTech has surged 600%. CanSino Biologics' stock is up about 440% over the same period. The company's single-dose Covid-19 vaccine was approved for use in China in February. Activists said the wealth generation highlighted the stark inequality that has resulted from the pandemic. The nine new billionaires are worth a combined $19.3 billion, enough to fully vaccinate some 780 million people in low-income countries. "These billionaires are the human face of the huge profits many pharmaceutical corporations are making from the monopoly they hold on these vaccines," Anne Marriott, Oxfam's health policy manager, said. "These vaccines were funded by public money and should be first and foremost a global public good, not a private profit opportunity," she added.
Note: You would hope that with all the suffering going on in our world, big Pharma wouldn't gouge and make huge profits on their vaccines. Sadly, this is far from the truth. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and the coronavirus vaccine from reliable major media sources.
For years, the Gates Foundation has been steered by an unusually small board of trustees, made up of Bill, his estranged wife, Melinda, and the billionaire investor Warren Buffett. The larger the foundation became, the less anyone seemed willing to ask tough questions about its secretive management structure or its penchant for giving money to lucrative pharmaceutical and credit card companies such as Mastercard, despite the fact that giving away billions to wealthy corporations set an unusual and troubling precedent in the philanthropic sector. Billionaires who make their fortunes through corporate practices that undercut workers and deepen inequality — like corporate tax avoidance, insufficient sick pay and the immoral gap in pay between executives and low-paid workers — are not the solution to problems they generate. Asking Bill Gates to fix inequality is like asking an arsonist to hose down your house after he just set it on fire. In April last year, the University of Oxford was reportedly considering offering a Covid-19 vaccine developed by its scientists on a nonexclusive basis. But then, Kaiser Health News reported, “Oxford — urged on by the Bill & Melinda Gates Foundation — reversed course. It signed an exclusive vaccine deal with AstraZeneca that gave the pharmaceutical giant sole rights and no guarantee of low prices.” This dealmaking .. seemed to conflict with the Gates Foundation’s stated mission to improve global access to medicines, but it’s not surprising.
Note: Read more about the Gates Foundation's startling degree of media influence during the pandemic. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the coronavirus vaccine from reliable major media sources.
A week ago, the Biden administration announced support for waiving intellectual property protection for Covid-19 vaccines. In response, Bio, a trade association representing biotechnology companies, issued a statement saying, “The United States has unfortunately chosen to set a dangerous precedent with these actions.” Efforts to maintain intellectual property rights from life-saving drugs to vaccines have hindered the global response. The Biden administration surprised a lot of observers by coming out in favor of this ... temporary suspension of IP and patent enforcement on certain medications related to the Covid-19 pandemic. Right now, the way that wealthier countries — the U.S. and others — are confronting this crisis for the developing world is through voluntary agreements. There are really two ways to combat this crisis. There’s a way to do it in a sense that maximizes profit for the healthcare companies, the pharmaceutical companies. And then there’s the more collaborative, nonprofit approach. And early on, pharmaceutical companies were fighting this more collaborative approach. The pharmaceutical companies, in addition, have said they plan to increase prices once the pandemic quote-unquote ends. These companies are eagerly awaiting the opportunity to increase prices.
The pharmaceutical industry is distributing talking points, organizing opposition, and even collecting congressional signatures in an attempt to reverse President Joe Biden’s support for worldwide access to generic Covid-19 vaccines. The behind-the-scenes moves ... come as the U.S. last week announced that it would support the World Trade Organization proposal, led by India and South Africa, to temporarily waive enforcement of intellectual property and patent rights on coronavirus vaccines. Without a radical expansion in vaccine manufacturing capacity, many developing countries will not achieve mass vaccination rates until 2023 or 2024. The waiver request, which was unexpectedly endorsed by Biden’s administration on May 5, is designed to provide legal immunity for drug firms to copy the formulas of existing vaccines to supply low-cost vaccines to low-income countries. On Wednesday, Jared Michaud, a lobbyist with the Pharmaceutical Research and Manufacturers of America, a trade group that represents Pfizer, Johnson & Johnson, AstraZeneca, and other major drug firms, sent an email laying out the industry’s role in coaxing lawmakers to push back against a waiver. One of the documents laid out potential national security concerns and suggested that lawmakers should argue the waiver could empower Russia and China. PhRMA ... spent over $24 million on federal lobbying last year and is one of the biggest corporate players in election spending.
Nearly 40% of US Marines are declining Covid-19 vaccinations, according to data provided to CNN on Friday by the service, the first branch to disclose service-wide numbers on acceptance and declination. As of Thursday, approximately 75,500 Marines have received vaccines, including fully vaccinated and partially vaccinated service men and women. About 48,000 Marines have chosen not to receive vaccines, for a declination rate of 38.9%. The declination rate at Camp Lejeune in North Carolina, one of the prominent Marine Corps bases, was far higher, at 57%, according to another set of data. Of 26,400 Marines who have been offered vaccinations, 15,100 have chosen not to receive them. The military cannot make the vaccines mandatory now because they have only emergency use authorizations from the Food and Drug Administration, meaning service members who are required to receive a series of other vaccinations have the option of declining shots to protect against Covid-19. Officials say most of the vaccine hesitancy stems from concerns about the speed at which the vaccines were developed and fears over long-term effects. The Defense Department has approximately 2.2 million service members operating around the globe.
Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.